跳至主要内容
临床试验/KCT0001753
KCT0001753招募中未知

Incidence of rifampin-resisitant Staphylococci after treating by rifaximin in patients of hepatic encephalopathy or spontaneous bacterial peritonitis

Ewha Womans University Medical Center0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
o Limit 至 o Limit(—)
性别
All

入选标准

  • Liver cirrhosis patient who taken rifaximin more than 7 days to prevent hepatic encephalopathy or to manage enterocolitis

排除标准

  • 1) who died or was follow up loss
  • 2) who treated with rifampin
  • 3) who administered rifaximin already
  • 4) who judged that cannot be enrolled by researcher

研究者

相似试验